---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-011854"
form_type: "8-K"
ticker: "CAPR"
cik: "0001133869"
company_name: "CAPRICOR THERAPEUTICS, INC."
filed_at: "2023-07-13T23:59:59+00:00"
generated_at: "2026-06-13T08:36:20.645711+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Capricor board member Manzo resigns; appoints Paul Auwaerter, M.D. to board

## Summary
- Louis Manzo resigned from board effective July 11, 2023, with no disagreement over operations.
- Manzo entered a consulting agreement to perform investor relations services for Capricor.
- Paul Auwaerter, M.D. appointed to board; receives initial option grant of 115,000 shares vesting over 3 years.
- Auwaerter is Clinical Director at Johns Hopkins Division of Infectious Diseases with over 30 years experience.

## SEC filing metadata
- accession: 0001558370-23-011854
- form_type: 8-K
- ticker: CAPR
- cik: 0001133869
- company_name: CAPRICOR THERAPEUTICS, INC.
- filed_at: 2023-07-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1133869/000155837023011854/0001558370-23-011854-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1133869/000155837023011854/capr-20230711x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-011854
- JSON: https://secwatch.observer/filing/0001558370-23-011854.json
- Plain text: https://secwatch.observer/filing/0001558370-23-011854.txt

## Key facts
- Executive change
  Louis Manzo resigned as member of the Board of Directors at CAPRICOR THERAPEUTICS, INC..
  - Action: resigned
  - Role: member of the Board of Directors
  source text: On July 11, 2023, Mr. Louis Manzo, a member of the Board of Directors (the “Board”) of Capricor Therapeutics, Inc., a Delaware corporation (the “Company”), resigned from the Board effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1133869/000155837023011854/0001558370-23-011854-index.htm
- Executive change
  Paul Auwaerter was elected as member of the Board of Directors at CAPRICOR THERAPEUTICS, INC..
  - Action: elected
  - Role: member of the Board of Directors
  source text: On July 11, 2023, the Board elected Paul Auwaerter, M.D. as a member of the Board, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1133869/000155837023011854/0001558370-23-011854-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.